Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a food aid shortage due to a 50% funding shortfall for the United Nations World Food Program, exacerbated by global crises like the war in Ukraine and drought in East Africa. With Uganda hosting more refugees than any other African country, the WFP has had to cut food supplies, leaving refugees like Konga, who has been in Uganda for six years, to rely on their kitchen gardens for survival. Vulnerable groups will continue to receive emergency aid, but others are expected to become self-sufficient, a challenge for those without sufficient land or resources.

Due to a 50% funding shortfall, the United Nations World Food Program has cut food aid for many refugees in Uganda, leaving them to rely on kitchen gardens for sustenance. Susan Konga, a South Sudanese refugee and single mother, fears she won't be able to grow enough to support her family, including paying for her nieces' school fees. WFP's country director, Marcus Prior, notes the global scale of needs forcing donors to make tough choices. Despite good rains, Konga and others face challenges in becoming self-sufficient and plead for continued aid.

Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a critical shortage of food aid due to a 50% funding shortfall for the United Nations World Food Program. The global crises, including the war in Ukraine and drought in East Africa, have led to reduced aid, forcing refugees to strive for self-sufficiency through kitchen gardens. Vulnerable groups will continue to receive emergency aid, but many like Konga, who lacks sufficient land, must now rely on their own cultivation, which poses challenges in meeting basic needs and covering school fees for dependents.

Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a critical shortage of food aid due to a 50% funding shortfall for the United Nations World Food Program (WFP). The global crises, including the war in Ukraine and drought in East Africa, have led to reduced aid, forcing refugees to strive for self-sufficiency through kitchen gardens. Vulnerable groups will continue to receive emergency aid, but many like Konga, who lacks sufficient land, must now depend on their own cultivation for survival, raising concerns about their ability to sustain themselves and afford basic needs.

Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a critical aid shortage due to a 50% funding shortfall for the United Nations World Food Program, leading to a cut in food supply for hundreds of thousands. With global crises diverting aid elsewhere, refugees must now rely on their own kitchen gardens for sustenance. Vulnerable groups will still receive emergency aid, but many like Konga, who lacks sufficient land, must strive for self-sufficiency amidst challenges like paying for school fees and surviving between harvests.

Refugees in Uganda, such as South Sudanese woman Susan Konga, are facing a critical aid shortage due to global crises and a funding shortfall for the United Nations World Food Program. With a 50% cut in funds, many refugees must now rely on kitchen gardens for self-sufficiency. Vulnerable groups will continue to receive emergency aid, but others are being weaned off. The WFP's $180 million deficit has forced difficult decisions, with refugees like Konga concerned about surviving between harvests and meeting basic needs.

Refugees in Uganda, such as South Sudanese woman Susan Konga, are facing a critical shortage of food aid due to a 50% funding shortfall for the United Nations World Food Program (WFP). The global crises, including the war in Ukraine and drought in East Africa, have led to reduced aid, forcing refugees to rely on kitchen gardens for self-sufficiency. Vulnerable groups will continue to receive emergency aid, but others must become independent, a challenge for those like Konga who lack sufficient land and resources.

Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a critical shortage of food aid due to a 50% funding shortfall for the United Nations World Food Program. This has led to a cut in food supplies for hundreds of thousands of refugees, forcing them to rely on kitchen gardens for self-sufficiency. Global crises, including the war in Ukraine and drought in East Africa, have exacerbated the situation. While vulnerable groups will continue to receive emergency aid, others must adapt to reduced support, a challenge that Konga fears will impact her ability to provide for her family's basic needs and her nieces' education.

Refugees in Uganda, such as South Sudanese single mother Susan Konga, are facing a critical shortage of food aid due to a 50% funding shortfall for the United Nations World Food Program. The global crises, including the war in Ukraine and drought in East Africa, have led to reduced aid, forcing refugees to strive for self-sufficiency through kitchen gardens. Vulnerable groups will continue to receive emergency aid, but others must adapt to the cut-off, a challenge for those like Konga who lack sufficient land and resources to become sustainable in the short term.

An injectable HIV treatment, containing cabotegravir and rilpivirine, offers new hope for patients in Uganda, including those facing stigma like Gerald Muwonge, a gay man and LGBTI rights activist. The treatment, developed by GlaxoSmithKline, has been approved by the World Health Organization and is undergoing a trial in Uganda with results expected in 2024. It has shown to outperform oral pills and requires dosing only once every two months. GSK plans to provide low-cost generic versions in the developing world by 2026 and is currently offering the regimen for free to governments for studies. Trials are also taking place in Kenya and South Africa, with the Joint Clinical Research Centre administering the trial in Uganda.

A new injectable HIV treatment, containing cabotegravir and rilpivirine, offers hope to patients in Uganda, including those facing stigma like activist Gerald Muwonge. The treatment, developed by GlaxoSmithKline, outperforms oral pills and is approved by the WHO. Trials are underway in Uganda, Kenya, and South Africa, with results expected in 2024. GSK plans to provide low-cost generics by 2026 and is offering the regimen free for studies. The Joint Clinical Research Centre in Uganda, with William Tamale managing the programme, is optimistic about the treatment's promise.

An injectable HIV treatment, developed by GlaxoSmithKline and containing cabotegravir and rilpivirine, offers new hope for patients in Uganda. The treatment, which outperforms oral pills, is administered once every two months and is currently undergoing a trial with results expected in 2024. It has been approved by the World Health Organization and U.S. authorities, with trials also taking place in Kenya and South Africa. Gerald Muwonge, an HIV-positive LGBTI rights activist, anticipates that the treatment could reduce the stigma associated with HIV, especially for the gay community in Uganda. GSK plans to provide low-cost generic versions in the developing world by 2026, and in the interim, is offering the regimen free of charge for studies.